Armin joins Sobi from Shire/Baxalta where he for the past 6 years has developed the Medical Affairs team within haemophilia and haematology as Head of Medical Affairs EMEA and Head of Medical Affairs Global, respectively.
He also has a long track record in basic research and clinical experience from academia, being a board certified specialist in transfusion medicine and Professor of Anatomy at the Ludwig Maximillian’s University in Munich, Germany.
“We are truly delighted to welcome Armin to Sobi”, says Geoffrey McDonough, President and CEO at Sobi. “Armin will apply his deep experience as an industry leader and academic in haemophilia to our team, as well as his global experience in Medical and Scientific Affairs to our stakeholders.”
Armin will lead Sobi’s cross-functional Medical & Scientific Affairs team, supporting Sobi’s patient centric approach.
Translating insights from the patient journey helps to understand patient needs and influences Sobi’s R&D and commercial strategy.
The Medical and Scientific Affairs team will continue to develop the robust scientific evidence base for the company’s rare disease portfolio.
“I am excited to join the team at Sobi, to contribute to the scientific foundation for the portfolio, and to further develop the patient centric approach that Sobi is pioneering in the rare disease field,” says Armin.
